Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Silk Road Medical Q1 2024 GAAP EPS $(0.36) Beats $(0.40) Estimate, Sales $48.484M Beat $44.676M Estimate

Author: Benzinga Newsdesk | April 30, 2024 04:28pm
Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 10 percent. This is a 16.28 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $48.484 million which beat the analyst consensus estimate of $44.676 million by 8.52 percent. This is a 20.81 percent increase over sales of $40.131 million the same period last year.

Posted In: SILK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist